| SNP-mediated disruption of CTCF binding at the IFITM3 promoter is associated with risk of severe influenza in humans EK Allen, AG Randolph, T Bhangale, P Dogra, M Ohlson, CM Oshansky, ... Nature medicine 23 (8), 975-983, 2017 | 176 | 2017 |
| Aging predisposes to acute inflammatory induced pathology after tumor immunotherapy MN Bouchlaka, GD Sckisel, M Chen, A Mirsoian, AE Zamora, E Maverakis, ... Journal of Experimental Medicine 210 (11), 2223-2237, 2013 | 154 | 2013 |
| Blocking indolamine-2, 3-dioxygenase rebound immune suppression boosts antitumor effects of radio-immunotherapy in murine models and spontaneous canine malignancies AM Monjazeb, MS Kent, SK Grossenbacher, C Mall, AE Zamora, ... Clinical cancer research 22 (17), 4328-4340, 2016 | 105 | 2016 |
| Hitting the target: how T cells detect and eliminate tumors AE Zamora, JC Crawford, PG Thomas The Journal of Immunology 200 (2), 392-399, 2018 | 102 | 2018 |
| Lung γδ T cells mediate protective responses during neonatal influenza infection that are associated with type 2 immunity JG Xi-zhi, P Dash, JC Crawford, EK Allen, AE Zamora, DF Boyd, S Duan, ... Immunity 49 (3), 531-544. e6, 2018 | 99 | 2018 |
| Tumor-intrinsic and-extrinsic determinants of response to blinatumomab in adults with B-ALL Y Zhao, I Aldoss, C Qu, JC Crawford, Z Gu, EK Allen, AE Zamora, ... Blood, The Journal of the American Society of Hematology 137 (4), 471-484, 2021 | 97 | 2021 |
| Pediatric patients with acute lymphoblastic leukemia generate abundant and functional neoantigen-specific CD8+ T cell responses AE Zamora, JC Crawford, EK Allen, XJ Guo, J Bakke, RA Carter, ... Science Translational Medicine 11 (498), eaat8549, 2019 | 83 | 2019 |
| Immunoediting and antigen loss: overcoming the achilles heel of immunotherapy with antigen non-specific therapies AM Monjazeb, AE Zamora, SK Grossenbacher, A Mirsoian, GD Sckisel, ... Frontiers in oncology 3, 197, 2013 | 74 | 2013 |
| Cell-intrinsic barriers of T cell-based immunotherapy HE Ghoneim, AE Zamora, PG Thomas, BA Youngblood Trends in molecular medicine 22 (12), 1000-1011, 2016 | 70 | 2016 |
| Influenza infection results in local expansion of memory CD8+ T cells with antigen non-specific phenotype and function GD Sckisel, JK Tietze, AE Zamora, HH Hsiao, SO Priest, DEC Wilkins, ... Clinical & Experimental Immunology 175 (1), 79-91, 2014 | 63 | 2014 |
| Models to study NK cell biology and possible clinical application AE Zamora, SK Grossenbacher, EG Aguilar, WJ Murphy Current protocols in immunology 110 (1), 14.37. 1-14.37. 14, 2015 | 35 | 2015 |
| Licensing delineates helper and effector NK cell subsets during viral infection AE Zamora, EG Aguilar, CM Sungur, LT Khuat, C Dunai, GR Lochhead, ... JCI insight 2 (10), 2017 | 31 | 2017 |
| Bystander activation and anti-tumor effects of CD8+ T cells following Interleukin-2 based immunotherapy is independent of CD4+ T cell help AM Monjazeb, JK Tietze, SK Grossenbacher, HH Hsiao, AE Zamora, ... PloS one 9 (8), e102709, 2014 | 28 | 2014 |
| Murine NK-cell licensing is reflective of donor MHC-I following allogeneic hematopoietic stem cell transplantation in murine cytomegalovirus responses CM Sungur, YJ Tang-Feldman, AE Zamora, M Alvarez, C Pomeroy, ... Blood, The Journal of the American Society of Hematology 122 (8), 1518-1521, 2013 | 28 | 2013 |
| Genome-wide CRISPR screen reveals PSMA6 to be an essential gene in pancreatic cancer cells J Bakke, WC Wright, AE Zamora, P Oladimeji, JC Crawford, CT Brewer, ... BMC cancer 19, 1-12, 2019 | 26 | 2019 |
| Transcription factor ZNF148 is a negative regulator of human muscle differentiation J Bakke, WC Wright, AE Zamora, SS Ong, YM Wang, JD Hoyer, ... Scientific Reports 7 (1), 8138, 2017 | 7 | 2017 |
| Antigen cross-presentation in young tumor-bearing hosts promotes CD8+ T cell terminal differentiation A Moustaki, JC Crawford, S Alli, Y Fan, S Boi, AE Zamora, ... Science immunology 7 (68), eabf6136, 2022 | 4 | 2022 |
| Adaptive Manufacturing of LV20. 19 CAR T-Cells for relapsed, Refractory Mantle Cell Lymphoma NN Shah, F Furqan, A Szabo, T Kearl, A Zamora, J Neumann, PN Hari, ... Blood 142, 1024, 2023 | 1 | 2023 |
| Simulating the Evolution of Signaling Signatures During CART-Cell and Tumor Cell Interactions V Shah, J Womack, AE Zamora, SS Terhune, RK Dash 2023 45th Annual International Conference of the IEEE Engineering in …, 2023 | 1 | 2023 |
| Chimeric antigen receptor-T (CAR-T) cell therapy targeting BCMA in patients with prior allogeneic transplantation (allo-HCT) in relapsed and/or refractory multiple myeloma (RRMM) L Hammons, S Haider, MC Pasquini, S Chhabra, S Radhakrishnan, ... Blood 140 (Supplement 1), 7215-7216, 2022 | 1 | 2022 |
